- Business
- Thompson MidCap Fund (THPMX) is an open-end mutual fund that seeks high long-term capital appreciation through investments primarily in equity securities of medium-sized companies. The fund normally invests at least 80% of its net assets plus any borrowing for investment purposes in a diversified portfolio of common stocks, American Depositary Receipts (ADRs), and real estate investment trusts (REITs) of companies falling within the 12-month average market capitalization range of the Russell Midcap Index, approximately $205 million to $152 billion as of December 31, 2024; it emphasizes companies with above-average potential for earnings and dividend growth across a blend of industries including technology (20.74%), financial services (15.20%), healthcare (14.93%), industrials (9.06%), and consumer cyclicals (8.75%). Top holdings as of recent data include Warner Bros. Discovery Inc. (5.15%), Neurocrine Biosciences Inc. (2.54%), O-I Glass Inc. (2.34%), Marvell Technology Inc. (2.28%), and Exact Sciences Corp. (2.27%), with a total of 76 equities, weighted average market cap of $32.6 billion, and median market cap of $12.7 billion. Launched on March 31, 2008, and managed by Thompson Investment Management, Inc., headquartered in Madison, Wisconsin, the fund operates with no sales charges, no 12b-1 distribution fees, no redemption fees, a minimum initial investment of $250, and a net expense ratio of 1.15%; it distributes dividends annually, with the latest payment on December 23, 2024, comprising $0.08200 income, $0.04830 short-term capital gain, and $0.94860 long-term capital gain at a reinvest price of $13.46. In recent developments, the fund maintained assets under management of approximately $53-55.62 million as of September 30, 2025, reflecting stable operations amid a low 27% holdings turnover rate and a beta of 1.23; portfolio managers James Evans and Jason Stephens continue to oversee the strategy since inception, with no reported acquisitions, partnerships, funding rounds, or major strategic shifts in the last 1-2 years, though the firm rebranded its mutual fund family from Thompson Plumb Funds to Thompson IM Funds in September 2012. The fund targets individual investors, financial advisors, and institutions seeking mid-cap blend exposure, primarily in U.S. stocks (90.69%), with minor non-U.S. stock (8.27%) and cash (1.03%) allocations, and is available for sale in the United States.